October 29 - November

Transcription

1 Les Pensières Veyrier-du-Lac (French Alps) October 29 - November Organized by The Mérieux Foundation and the London School of Hygiene & Tropical Medicine

2 ACDx enhances the knowledge and professional network of policy-makers and scientists. The week-long intensive course provides them with an overview of the latest advances in the field of diagnostics. Leading global experts address the social, economic, political and ethical issues of diagnostics through a variety of learning techniques. During this year s course, participants can also expect to discuss laboratory system strengthening, surveillance and emergency outbreak response, and take an in-depth look at antimicrobial resistance. Hosted less than an hour from Geneva, on the shores of Lake Annecy at Les Pensières Center for Global Health, the course offers plenty of opportunity for networking and exchange among participants and faculty. KEY FIGURES 40 HIGHLY SELECTED PARTICIPANTS 35 INTERNATIONAL SPEAKERS 10 INTERACTIVE SESSIONS 7 SUCCESSFUL YEARS 6 DAYS OF KNOWLEDGE-SHARING 1 DIPLOMA A NETWORK OF 250 ALUMNI Graciela Russomando Professor - Universidad Nacional de Asunción (Paraguay) Considering the advances in technology, why is it not yet possible to have access to rapid, easy-to-use instruments in our countries, especially at the rural clinic level? Leadership initiatives are needed in our regions to promote the benefits of early diagnosis, generating clear gains in public health programs. ACDx is a unique opportunity to foster such initiatives and share experiences with others! 2

3 SCIENTIFIC ADVISORY BOARD ROSANNA PEELING (Course director) London School of Hygiene & Tropical Medicine (UK) FRANCOIS-XAVIER BABIN (Co-director) Mérieux Foundation (France) ANNELIES WILDER-SMITH (Director of partnerships) London School of Hygiene & Tropical Medicine (UK) ALASH'LE ABIMIKU African Society for Laboratory Medicine (Ethiopia) CATHARINA BOEHME Foundation for Innovative New Diagnostics (Switzerland) XIANG-SHENG CHEN National Academy of Medical Sciences and Center for Disease Control (China) JAMES CUMMINGS Formerly Global Emerging Infections Surveillance and Response Program, GEIS (USA) NIRMAL GANGULY Formerly of the Indian Council of Medical Research (India) MARK MILLER Bethesda, MD (USA) FRANCIS MOUSSY World Health Organization (Switzerland) MAURINE MURTAGH International Diagnostics Centre (UK) JEAN-BOSCO NDIHOKUBWAYO World Health Organization Regional Office for Africa (Republic of the Congo) JOHN NKENGASONG Africa Centres for Disease Control and Prevention (Ethiopia) TREVOR PETER Clinton Health Access Initiative (Botswana) GRACIELA RUSSOMANDO Universidad Nacional de Asunción (Paraguay) ANDRZEJ RYS European Commission (Belgium) JEAN SAKANDÉ University Hospital Yalgado Ouédraogo (Burkina Faso) DAVID HEYMANN London School of Hygiene & Tropical Medicine (UK) NADIA KHELEF Institut Pasteur (France) SOULEYMANE MBOUP Cheikh Anta Diop University (Senegal) 3

4 Sunday, October 29 th Overview of the Role of Diagnostics in Global Health To learn about the role of diagnostics in global health and to combat AMR To learn about the Africa CDC AMR Surveillance Network Guiding clinical decision-making Guiding public health emergency response Diagnostics as part of the AMR response Special Session Opening Address: The WHO Global Action Plan in response to Antimicrobial Resistance UNAIDS response to AMR Launch of the Africa CDC AMR Surveillance Network (AMRSNET) Introducing AMRSNET: Goals and plan of action AMRSNET support: Fleming Fund, LSHTM-BD AMR Partnership Institut Pasteur Networks contribution to AMRSNET Round Table: country plans and Africa AMRSNET Monday, October 30 th MORNING Quality Policy in Diagnostics To learn the importance of the quality-assured diagnostics for public health programs To learn about international quality standards in diagnostics, how to implement quality policy and to share best practice The diagnostic quality continuum Industry panel on quality by design and manufacturing Ensuring quality through regulation and quality assurance Best practice: post-market surveillance, storage, transport and distribution; the USP Quality Institute Laboratory quality standards Quality assurance for Point-of-Care diagnostics Debate: QA for POC testing, centralized vs decentralized systems 4

5 AMR Diagnostic Stewardship and Surveillance To learn global, regional and country AMR strategies and policies To learn the role that quality-assured diagnostics play in implementing AMR strategies, policies and action plans AMR Surveillance Technology Forum: eposters and demonstrations Genotypic AMR assays Phenotypic AMR assays Whole genome sequencing Identifying markers of resistance AMR Surveillance networks: management, analysis and utilization; opportunities for public-private partnerships AMRSNET Institut Pasteur networks Respiratory pathogen networks Enteric pathogen networks Gonococcal Resistance networks Scoring system for AMR surveillance competency: ensuring quality and timeliness of surveillance data Tuesday, October 31 st MORNING From Basic Research to a Commercialized Diagnostic Test To learn the challenges of developing and bringing to market diagnostic tests for infectious diseases To explore options for collaborative research and development (R&D) to accelerate the pathway to market for global health, especially for epidemic preparedness and AMR Challenges of diagnostics R&D for global health: Overview of the long road from R&D to adoption Panel discussion: lessons learned from test development and approval for use in past outbreaks Access to specimens for test development, evaluation and quality assurance Evaluation of diagnostics Technological innovation and regulatory science Debate: Open platform technologies: dream or reality? 5

6 State of Art Diagnostics and Diagnostics to Combat AMR To learn the state of the art diagnostics for major infectious diseases To learn how Point-of-Care (POC) diagnostics can be used to reduce misuse of antibiotics State of the Art Diagnostics Forum: HIV, TB, Malaria, Hepatitis, neglected tropical diseases, respiratory infections, enteric infections, sexually transmitted infections, arboviruses, haemorrhagic fevers Stations with e-posters that summarize state-of-art diagnostics for each of the disease/syndromes listed above. An expert will be available at each station for questions and discussions. POC tests to reduce misuse of antibiotics: A simple rapid test to distinguish between bacterial and viral infections How can the long pathway from R&D to adoption be accelerated without compromising quality? Fever Pneumonia Enteric infections Reports back from breakout groups and discussion Wednesday, November 1 st MORNING Diagnostic System Strengthening Review laboratory Infrastructure required to support global health priorities Review challenges in diagnostic systems (laboratory and Point-of-Care test systems) with respect to quality, capacity building, accreditation, data, governance, biosafety and waste management Overview: pillars supporting successful implementation and delivery of diagnostics Laboratory systems: Role of public health and national reference laboratories Adaptable laboratory network structures within national health care systems Diagnostic system strengthening initiatives: Program and tools for capacity building Others from participants Tools for assessing competencies (WHO ASLM scoring system) Human resource management for laboratories Data connectivity and governance Biosecurity and biosafety for laboratory systems Waste management Free for networking, tutorials special sessions. 6

7 Thursday, November 2 nd MORNING Sustainable Diagnostic Systems To explore options for public and private partnerships to build sustainable diagnostic systems to meet public health needs To learn about initiatives for technological innovation in diagnostics for AMR Building sustainable national, regional and global diagnostic systems to meet public health needs Breakout groups: Building sustainable laboratory systems Financing laboratory systems Reports from breakout groups Round table: funding for innovative technologies for AMR Longitude Prize Japanese group for global health Global AMR Innovation Fund Others Diagnostics for Antimicrobial Resistance: the Way Forward To brainstorm on innovation needed for countries to use diagnostic tests effectively to combat AMR How to share tools and experiences Diagnostics for AMR Round Table: Social Innovation in Health Education: crowdsourcing for AMR cases for e-learning Other initiatives Sharing tools and experiences for AMR Debate: topic to be chosen by participants Friday, November 3 rd Partnerships and Networks Learn about ways to communicate through networks, websites and other opportunities Brainstorm on key elements in building successful partnerships and networks for emergency preparedness Partnerships and networking platforms ACDx e-community / Alumni networks RESAOLAB/RESAMAD Institut Pasteur network AMR surveillance networks Other networks CLOSING LUNCH 7

8 WHO SHOULD APPLY? Scientists and decision-makers involved in the development of diagnostic tools or in the design and implementation of strategies and policies on the use of diagnostics in the control of infectious diseases at national and international levels For both private and public sectors PROGRAM FEES The fees include tuition, course material, accommodation costs and three meals a day for the full period of the course. Participants from academic/governmental institutions & NGOs benefit from reduced fees: 3,000 VAT included Participants from industry fees: 6,000 VAT included If accepted, participants will be required to pay all of the fees in full to confirm their participation CONTACT Katia Mielczarek katia.mielczarek@fondation-merieux.org See additional information on 8